Immix Biopharma announces closing of $125 million underwritten offering of common stock
IMMX•Immix Biopharma announced the closing of a $125 million underwritten offering of common stock.
1. Offering closed
Immix Biopharma announced the closing of a $125 million underwritten offering of common stock.
